Healthcare Global Enterprises Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Healthcare Global Enterprises has today launched its new comprehensive cancer hospital in Hebbal with up to 132 beds, strengthening access to advanced oncology care in North Bengaluru (HCG Cancer Hospital, Hebbal). The new facility marks a major advancement in the region's oncology landscape, bringing together clinical excellence, compassionate care and advanced technology to make world-class cancer treatment more accessible to people across Karnataka.

Marking a significant milestone in precision oncology, the new facility introduces Karnataka's first Elekta Unity MR-Linac, one of the world's most advanced precision radiation therapy platforms. The technology combines high-quality MRI imaging with a linear accelerator to enable highly precise, adaptive cancer treatment. Designed as a full-spectrum oncology centre, the hospital brings together diagnosis, treatment, recovery support, and patient-centric care under one roof, making world-class cancer care more accessible to patients across North Bengaluru.

Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 19 May 2026.

The board of Healthcare Global Enterprises at its meeting held on 24 February 2025 has approved the terms of rights issue:

Instrument: Fully paid-up equity shares of face value of Rs 10 each.

Total number of Rights Equity Shares and Rights Issue size: 82,94,566 Rights Equity Shares each for an amount aggregating to Rs 424.68 crore (assuming full subscription and payment of call monies).

Rights Issue Price: Rs 512 (Rupees Five Hundred and Twelve only) per Rights Equity Share (including a premium of Rs 502 (Rupees Five Hundred and Two only) per Rights Equity Share)

Concept of Rights Entitlement: The shareholders holding equity shares of the Company as on the Record date (?eligible equity shareholders?) will be entitled to Rights Entitlement (?REs?). REs shall be credited prior to the issue opening date, in the respective demat account of the eligible equity shareholders (?RE Holders?) under the ISIN: INE075I20017. The Company has made necessary arrangements with NSDL and CDSL for credit of REs in the respective demat account of the eligible equity shareholders. RE holders can apply for Rights Issue or renounce the REs in full or in part.

Record date: 02 March 2026

Issue opening date: 11 March 2026

Issue closing date: 25 March 2026

Date of listing of rights issue: 01 April 2026

Rights Entitlement Ratio: The Rights Equity Shares are being offered on a rights basis to Eligible Equity Shareholders in the ratio of 1 (One) Rights Equity Shares for every 17 (Seventeen) fully paid-up Equity Shares held on the Record Date.

Powered by Capital Market - Live News

Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 24 February 2026.

Powered by Capital Market - Live News